{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:39:13Z","timestamp":1768001953523,"version":"3.49.0"},"reference-count":27,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anticancer Therapy"],"published-print":{"date-parts":[[2022,4,3]]},"DOI":"10.1080\/14737140.2022.2049763","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T09:29:05Z","timestamp":1646645345000},"page":"335-341","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":14,"title":["Current and emerging role of sacituzumab govitecan in the management of urothelial carcinoma"],"prefix":"10.1080","volume":"22","author":[{"given":"Vinay","family":"Mathew Thomas","sequence":"first","affiliation":[{"name":"Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishita","family":"Tripathi","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neeraj","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umang","family":"Swami","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002788"},{"key":"cit0002","unstructured":"National Comprehensive Cancer Network. Bladder cancer (version 6.2021 [cited 2021 Dec 6]. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/bladder.pdf"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2021.100325"},{"key":"cit0004","unstructured":"US Food and Drug Administration. FDA grants accelerated approval to sacituzumab govitecan for advanced urothelial cancer 2021. [cited 2021 Oct 24]. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-sacituzumab-govitecan-advanced-urothelial-cancer"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03489"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30030-4"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.268"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-015-1624-3"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2011.539557"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-07-2003"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.18632\/genesandcancer.40"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2009.12.019"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604677"},{"key":"cit0014","unstructured":"Leung K. (89)Zr-Desferrioxamine-anti-epithelial glycoprotein-1 hRS7 humanized monoclonal antibody. Molecular Imaging and Contrast Agent Database (MICAD). Bethesda (MD) 2004."},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2019.1632115"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.2174\/1389450117666160502151707"},{"key":"cit0017","first-page":"1","volume":"22","author":"Schreiber AR","year":"2021","journal-title":"Expert Rev Anticancer Ther"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy254"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-0670"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1814213"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-3321"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30789"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2008.05.002"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2015.10.002"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.7_suppl.354"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.5027"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2021.39.6_suppl.TPS498"}],"container-title":["Expert Review of Anticancer Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737140.2022.2049763","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T14:29:21Z","timestamp":1649428161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737140.2022.2049763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4,3]]}},"alternative-id":["10.1080\/14737140.2022.2049763"],"URL":"https:\/\/doi.org\/10.1080\/14737140.2022.2049763","relation":{},"ISSN":["1473-7140","1744-8328"],"issn-type":[{"value":"1473-7140","type":"print"},{"value":"1744-8328","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-01-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}